核BIN1异型调节c-Myc介导的细胞循环控制在寡头质细胞.
bioRxiv : the preprint server for biology
|November 19, 2025
概括
桥梁整合体1 (BIN1) 蛋白质在寡细胞 (OLs) 的失调与阿尔茨海默病 (AD) 有关. 核BIN1异型调节OL细胞周期,它们的改变表达有助于AD的髓病理.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 桥梁整合剂1 (BIN1) 是一种抑制c-Myc的瘤抑制蛋白,在寡细胞 (OLs) 中表达高.
- BIN1变种是散发性阿尔茨海默病 (AD) 的重要遗传风险因素.
- 在OLs中,特别是AD中,BIN1异型的调节和功能尚不清楚.
研究的目的:
- 为了表征阿尔茨海默病 (AD) 大脑和小鼠模型中的OLs中的BIN1异型.
- 调查核BIN1在OLs中的作用及其对AD病理学的潜在贡献.
主要方法:
- 在死后人类AD大脑和APP/PS1小鼠上进行免疫血清和免疫组织化学检查.
- 分析初级小鼠OL培养物,包括OL原生细胞 (OPC) 中的Bin1沉默.
- 转录基因分析和in silico相互作用研究.
主要成果:
- 在AD病例和小鼠模型中,神经元BIN1异型 (BIN1:H) 减少,而OL特异性异型 (BIN1:L) 增加.
- 在人类和小鼠的OL (OPC和成熟的OL) 中确认了OL特定BIN1异型的核定位.
- 在OPCs中,Bin1沉默改变了转录组特征,影响了p53通路和细胞周期调节,与减少c-Myc抑制相一致.
结论:
- 核BIN1异型体作为OL细胞循环控制的调节剂.
- 在OLs中BIN1的调节失调可能会在偶尔的AD中机制性地导致髓病理.
- 这些发现突显了BIN1在OLs中的作用及其对阿尔茨海默氏症病原发生的影响.
更多相关视频
08:33Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis
Published on: December 5, 2017
14.8K
12:26Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
19.3K
相关概念视频
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Positive Regulator Molecules
6.4K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
6.4K
Positive Regulator Molecules
133.9K
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
133.9K
Regulation of Nuclear Protein Sorting
3.2K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
3.2K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
M-Cdk Drives Transition Into Mitosis
6.2K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.2K
